Hospital Foch — Clinical Trial Site

208 Registered trials

96 Currently recruiting

Organisation

Hospital Foch

Location

Suresnes, France

Identifier

ORG-100009584

Address

40 Rue Worth, 92150, France

Departments

1021:Neurologie
106: Oncologie
1705:Medical Oncology
2302: Oncologie
2313 Oncology Medical
2404:Service d'Oncologie Medicale
405: Oncologie
92
Anaestesia
ANESTHESIE - REANIMATION
Anesthésie Réanimation
Anesthésie-Réanimation-Médecine de la douleur
Anesthesiolgy
Anethésie et douleurs
Cancérologie
Cardiologie
Cardiology
Departement d'Oncologie Medicale
Département d'oncologie médicale
Departement d'oncologie medicale et soins de support
Département d'urologie
Departement d’Oncologie
Departement d’oncologie medicale
Department Medical Oncology
Department of Medical Oncology
Department of pneumology
Hôpital Foch
Hôpital Foch (#1)
Internal Medecine
Internal medicine
Médecine Interne
Médecine Interne Unité d'Immunologie Clinique
Medical oncology
Medical Oncology Department
N/A
Nephrologie
nephrology
Neurologie
Neurology
Neuroradiologie
Neuroradiologie Interventionnelle
Neuroscience
Neurosurgery
Neurosurgery for adults
NRI
Onco Pneumologie
Oncologie
Oncologie et soins de supports
Oncologie médicale
Oncologue
Oncology
Oncology for adults
penumology
PMA
Pneumologie
pneumology
Réanimation polyvalente
Réanimation polyvalente et ISU neurochirurgicale
Respiratory direases
respiratory disease
Respiratory medicine
Service d Oncologie
Service d oncologie medicale et service de pneumologie
Service d'oncologie medicale
Service d'Urologie
Service d’Oncologie Médicale
Service d’urologie
Service d’urologie et de transplantation rénale
Service de chirurgie ophtalmologique
service de médecine interne
Service de Néphrologie
Service de Nephrologie Dialyse et Transplantation Rénale
Service de Neurologie - Unité Neurovasculaire
Service de Neurologie et Unité Neurovasculaire
Service de Pneumologie
Service de Pneumologie (Adultes)
Service de Réanimation
Service de Réanimation - Intensive Care
Service Néphrologie Hôpital Foch
Service Oncologie
Services de Pneumologie & d’Oncologie Médicale
Unité transversale d'Infectiologie
Urologie
Urology

Clinical trials at this site (208)

Search interface

RIISC Recruiting

2024-513669-38-00 Stroke, Ischemic, TIA, Cardiac Disease, Atherosclerosis 5 2023-05-17
REVERT : REVErsing airway Remodelling with Tezepelumab Recruiting

2024-513195-18-00 Severe asthma 5 2023-03-27
Maintenance Pembrolizumab at Usual or Low doSE in non-squamous lung cancer: a non-inferiority study Recruiting

2023-503481-23-00 Maintenance treatment in metastatic non-squamous lung c 5 2023-03-20
Piperacillin-tazobactam and temocillin as carbapenem-alternatives for the treatment of severe infections due to extended-spectrum beta-lacta… Recruiting

2024-511866-36-00 patients hospitalized in ICU with ESBL-producing Entero 5 2023-03-11
Study of Neoadjuvant and Adjuvant Treatment in Patients with Resectable Non-small Cell Lung Cancer Recruiting

2023-508852-21-00 Resectable, Early-stage (II to IIIB) Non-small Cell Lun 4 2022-06-10
Randomised phase III trial of ADT +/- darolutamide in frail men with castration-naïve de novo metastatic prostate cancer Recruiting

2022-502425-18-00 Adenocarcinoma of the prostate 5 2022-04-19
A Study with ABBV-CLS-484 Alone and in Combination in Subjects with Advanced Tumor Cancer Recruiting

2023-507568-38-00 Metastatic or locally advanced tumors 1 2022-01-14
Multicenter randomized two arms study evaluating the efficacy of prophylactic Rituximab in EBV negative kidney transplant recipients on inci… Recruiting

2024-515075-36-00 kidney transplantion -Epstein Barr virus 6 2021-12-01
Predictive Signature of Benralizumab Response. BENRAPRED Study. Recruiting

2024-514843-27-00 Severe asthma 6 2021-10-11
Short Treatment With Omalizumab for Severe Asthma (SHORTEN) Recruiting

2024-513427-17-00 Well controlled severe allergic asthma 6 2021-05-20
A multicenter, prospective, randomized, placebo-controlled, double-blind, multi-arm, multi-stage clinical trial of Ivabradine for heart Rate… Recruiting

2024-515019-22-00 Septic shock 5 2021-02-26
Pan tumor Roll Over Study Recruiting

2023-506914-32-00 Pan tumor 4 2020-05-05
MAINEPSAN : A Prospective Comparative Randomized Double-blind Placebo-controlled In-Parallel Groups Multicenter, Study to Evaluate the remis… Recruiting

2024-514156-33-00 Patients in remission for granulomatosis with polyangii 5 2019-08-20
First-line Chemotherapy With Temozolomide Alone for Non-enhancing Adult Brainstem Gliomas, With a Diffuse Subtype and Showing Clinical and/o… Recruiting

2024-511862-35-00 Adults with non-contrast-enhancing diffuse brainstem gl 4 2019-07-19
A Phase III trial of acetylsalicylic acid and atorvastatin in patients with castrate-resistant prostate cancer (PEACE 4) Recruiting

2023-508072-11-00 Castration-resistant prostate cancer 5 2019-06-26
A Phase II Open-Label Study of Sacituzumab Govitecan in Unresectable Locally Advanced/Metastatic Urothelial Cancer Recruiting

2023-508302-24-00 Locally Advanced/Metastatic Urothelial Cancer 4 2019-05-07
Avoid Anticoagulation After IntraCerebral Haemorrhage Recruiting

2024-514094-22-00 Intrecerebral Haemorrhage 5 2019-01-18
Extension Study for Participants in Studies That Include Pembrolizumab Recruiting

2022-501254-10-00 Advanced tumors 5 2018-08-24
CLAZI : CLArithromycin versus AZIthromycin in the treatment of Mycobacterium avium complex pulmonary infections: A randomized prospective co… Recruiting

2024-518578-15-00 Is to demonstrate a non inferior efficacy of azithromyc 5 2018-02-05
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication: BIOMEDE 2.0 Recruiting

2023-506027-29-00 Children, adolescents and adults with newly diagnosed d 5 2014-10-01
A Study of Subcutaneous Nivolumab plus Intravenous Ipilimumab and Chemotherapy in Participants with Previously Untreated Metastatic or Recur… Ended

2024-520108-25-00 Non-small cell lung cancer (NSCLC) 4 2025-11-05
Study of zoldonrasib in Previously Treated Patients with RAS G12D-Mutant Non-Small Cell Lung Cancer (NSCLC) Ended

2025-521681-10-00 Lung Cancer 4 2025-10-02
Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer Ended

2025-521115-40-00 Advanced or Metastatic Non-small Cell Lung Cancer 4 2025-09-30
Phase 1b/2 Study of Anti-CEACAM5 ADC Precemtabart Tocentecan (M9140) in Participants With Advanced Gastric Cancer (Substudy GC) Ended

2024-517817-34-00 Gastric Cancer 9 2025-06-18